These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20064648)

  • 21. Has surveillance been adequate to detect endemic measles in the United States?
    Harpaz R; Papania MJ; McCauley MM; Redd SB
    J Infect Dis; 2004 May; 189 Suppl 1():S191-5. PubMed ID: 15106110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Can the sub-notification of drug adverse effects by capture/recapture method be evaluated?].
    Jonville-Béra AP; Autret E
    Therapie; 1996; 51(2):169-75. PubMed ID: 8763052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serious underreporting of visceral leishmaniasis through passive case reporting in Bihar, India.
    Singh SP; Reddy DC; Rai M; Sundar S
    Trop Med Int Health; 2006 Jun; 11(6):899-905. PubMed ID: 16772012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The knowledge, attitude and practices of the reporting of notifiable diseases among health workers in Yobe State, Nigeria.
    Bawa SB; Olumide EA; Umar US
    Afr J Med Med Sci; 2003 Mar; 32(1):49-53. PubMed ID: 15030066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The functional status of disease surveillance and notification system at the local government level in Yobe State, Nigeria.
    Bawa SB; Umar US
    Niger J Clin Pract; 2009 Mar; 12(1):74-8. PubMed ID: 19562926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a measles vaccine efficacy during a measles outbreak in Mbare, City of Harare Zimbabwe.
    Mahomva AI; Moyo IM; Mbengeranwa LO
    Cent Afr J Med; 1997 Sep; 43(9):254-6. PubMed ID: 9509644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A million dollar measles outbreak: epidemiology, risk factors, and a selective revaccination strategy.
    Robertson SE; Markowitz LE; Berry DA; Dini EF; Orenstein WA
    Public Health Rep; 1992; 107(1):24-31. PubMed ID: 1738804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measles exportation from Japan to the United States, 1994 to 2006.
    Takahashi H; Saito H
    J Travel Med; 2008; 15(2):82-6. PubMed ID: 18346240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measles mortality in India: a review of community based studies.
    Singh J; Sharma RS; Verghese T
    J Commun Dis; 1994 Dec; 26(4):203-14. PubMed ID: 7759802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lessons learned from establishing and evaluating indicators of the quality of measles surveillance in the United States, 1996-1998.
    Harpaz R; Papania MJ; Fujii KE; Redd SB; Wharton ME; Redd SC; Gindler J
    J Infect Dis; 2004 May; 189 Suppl 1():S196-203. PubMed ID: 15106111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Herd immunity to measles virus in a population of student nurses and medical students following a widespread outbreak of clinical measles in Ibadan, Nigeria.
    Forbi JC; Kfutwah AK; Oyedele OI; Adu FD; Odemuyiwa SO
    West Afr J Med; 2000; 19(4):309-11. PubMed ID: 11391847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reliability of the clinical surveillance criteria for measles diagnosis.
    Blackburn N; Schoub B; O'Connell K
    Bull World Health Organ; 2000; 78(6):861. PubMed ID: 10916925
    [No Abstract]   [Full Text] [Related]  

  • 33. First evaluation of completeness and sensitivity of the measles surveillance system in the Czech Republic, January 1, 2018 until June 30, 2019.
    Liptáková M; Špačková M; Príkazský V; Limberková R; Repelová S; Orlíková H; Balasegaram S; Částková J
    Epidemiol Mikrobiol Imunol; 2022; 71(2):109-117. PubMed ID: 35940865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute measles mortality in the United States, 1987-2002.
    Gindler J; Tinker S; Markowitz L; Atkinson W; Dales L; Papania MJ
    J Infect Dis; 2004 May; 189 Suppl 1():S69-77. PubMed ID: 15106092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A capture-recapture estimate of inflammatory bowel disease prevalence: the Florence population-based study.
    Palli D; Masala G; Trallori G; Bardazzi G; Saieva C
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):50-3. PubMed ID: 9615266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measles surveillance in five major US cities: Chicago, Houston, Los Angeles, Miami, and New York.
    Kolasa M; Alexopoulos N; Diaz P; Kellachan J; Lowrey MJ; Shelton B; Harpaz R; Papania MJ
    J Infect Dis; 2004 May; 189 Suppl 1():S216-21. PubMed ID: 15106114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A ten-year study of measles admissions in a Nigerian teaching hospital.
    Fetuga MB; Jokanma OF; Ogunfowora OB; Abiodun R
    Niger J Clin Pract; 2007 Mar; 10(1):41-6. PubMed ID: 17668714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measles hospitalizations, United States, 1985-2002.
    Lee B; Ying M; Papania MJ; Stevenson J; Seward JF; Hutchins SS
    J Infect Dis; 2004 May; 189 Suppl 1():S210-5. PubMed ID: 15106113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Timely measles surveillance in the Republic of Korea, 2002-2009: impact of sentinel laboratory surveillance.
    Choe YJ; Eom HS; Bae GR; Cho SI
    J Med Virol; 2014 Feb; 86(2):322-8. PubMed ID: 24027198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surveillance of measles in England and Wales: implications of a national saliva testing programme.
    Ramsay M; Brugha R; Brown D
    Bull World Health Organ; 1997; 75(6):515-21. PubMed ID: 9509623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.